v3.26.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes the activity relating to the Company’s market-based stock options for the three-month period ended June 30, 2026:

Options
(in thousands)
Weighted-
Average
Exercise Price
($)
Weighted-Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2026
5,09014.09 — — 
Granted— — — 
Exercised— — — 
Forfeited— — — 
Outstanding as of June 30, 2026
5,09014.095.68$687 
Exercisable as of June 30, 2026
— — $— 
The following table summarizes the activity relating to the Company’s stock options, excluding the market-based stock options, for the three-month period ended June 30, 2026:

Options
(in thousands)
Weighted-
Average
Exercise Price
($)
Weighted-Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2026
1,8074.51 — — 
Granted— — — 
Exercised— — — 
Forfeited(182)4.66 — — 
Outstanding as of June 30, 2026
1,6254.495.50$346 
Exercisable as of June 30, 2026
1,5754.50 5.42$346 
Schedule of Restricted Stock Activity
A summary of all unvested restricted stock, RSUs and PSUs for the three-month period ended June 30, 2026 is as follows:

Time-Based Awards

Market-Based AwardsPerformance-Based Awards
Number of
Unvested Shares
(in thousands)
Weighted- Average
Grant Date Fair Value
($)
Number of
Unvested Shares
(in thousands)
Weighted- Average
Grant Date Fair Value
($)
Number of
Unvested Shares
(in thousands)
Weighted- Average
Grant Date Fair Value
($)
Unvested, March 31, 2026
1,9854.248345.35 3,9934.05 
Granted— — 
Vested/Exercised
(1)4.75— — — — 
Forfeited or expired— — 
Unvested, June 30, 2026
1,9844.23 8345.35 3,9933.62 
Schedule of Unvested SARs Activities
The following table summarizes the activity relating to the Company’s stock appreciation rights (“SARs”) for the three-month period ended June 30, 2026:

Number of SARs
(in thousands)
Weighted-
Average
Exercise Price
($)
Weighted-Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2026
2,3692.36 
Granted— — 
Exercised(312)2.52 
Forfeited0— 
Outstanding as of June 30, 2026
2,0572.342.26
Exercisable as of June 30, 2026
9712.42 2.06$1,367 
Schedule of Fair Value Valuation Assumptions
The fair value of each warrant on grant date is estimated using the Black-Scholes option-pricing model reflecting the following assumptions:

Expected volatility 70.0 %
Expected life of warrants
5.2
Risk free interest rate4.0 %
Dividend yield— 
Fair value of warrants granted during the quarter
$2.79